Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity

NCT04099667 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

272

Enrollment

INDUSTRY

Sponsor class

Conditions

Spasticity

Interventions

DRUG: Phase 2; Low Dose MYOBLOC
DRUG: Phase 2; High Dose MYOBLOC
DRUG: Phase 2; Placebo
DRUG: Phase 3; MYOBLOC
DRUG: Phase 3; Placebo

Sponsor

Supernus Pharmaceuticals, Inc.

Collaborators

[object Object]